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Abstract
Objectives: In most countries, life expectancy at birth (e0)
has improved for many decades. Recently, however, pro-
gress has stalled in the UK and Canada, and reversed in the
USA. Lifespan variation, a complementary measure of mor-
tality, increased a few years before the reversal in the USA.
To assess whether this measure offers additional meaning-
ful insights, we examine what happened in four other high-
income countries with differing life expectancy trends.
Design: We calculated life disparity (a specific measure of
lifespan variation) in five countries – USA, UK, France,
Japan and Canada – using sex- and age specific mortality
rates from the Human Mortality Database from 1975 to
2017 for ages 0–100 years. We then examined trends in
age-specific mortality to identify the age groups contribut-
ing to these changes.
Setting: USA, UK, France, Japan and Canada
Participants: aggregate population data of the above
nations.
Main Outcome Measures: Life expectancy at birth, life
disparity and age-specific mortality.
Results: The stalls and falls in life expectancy, for both
males and females, seen in the UK, USA and Canada coin-
cided with rising life disparity. These changes may be driven
by worsening mortality in middle-age (such as at age 40).
France and Japan, in contrast, continue on previous
trajectories.
Conclusions: Life disparity is an additional summary meas-
ure of population health providing information beyond that
signalled by life expectancy at birth alone.
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Introduction
Life expectancy at birth (denoted e0) is an efficient
summary of population health and how it changes
over time. In the absence of extraordinary events –
such as wars, environmental disasters and pandemics
– e0 has trended steadily upwards in most populations
in recent decades. Where it has fallen, other than tran-
siently, it has often been associated with major crises,
such as the AIDS pandemic, wars, famines or state
collapse as in the ex-USSR.1,2 While the eventual con-
sequences of the COVID-19 pandemic remain
unknown, the UK has experienced a fall in e0 of 0.9
and 1.2 years for females and males, respectively.3
Given the long-term improvement in e0 prior to the
pandemic in most high-income nations, any stalling
in trends – i.e. prolonged increases slower than the
long-term average – demand explanation. Identifying
the cause of a falling e0 requires careful examination of
mortality data by sex, age group and cause of death.
This is especially important as improvements in some
subgroups may, to some extent, compensate for
declines or stalls in other subgroups. For example, in
the 1980s, concern about the slowdown in what had,
until then, been increasing life expectancy in countries
ofCentral andEasternEuropemight have been greater
if it had been widely recognised that continuedmortal-
ity gains in infancy and childhoodwere obscuring wor-
sening in adult mortality.4 Thus, like any summary
measure, e0 can conceal details with practical or
policy importance, so there is a strong theoretical argu-
ment to look at other measures, in particular those
capturing the distribution of mortality.
Lifespan variation is a term covering a class of
complementary measures to e0 which measure the
variability of age at death among individuals within
a defined population.5 Typically, as e0 increases, life-
span variation decreases; those countries with the
highest e0 also have the lowest lifespan variation:6 a
phenomenon also observed in other primate species.7
This is, in part, because the maximal attainable life-
span has changed little but death rates at younger
ages have tended to fall. The measure of lifespan
variation we use is life disparity, which measures
the average gap between an individual’s age at
death and their remaining life expectancy at that
age.6 Some have argued that life disparity has a ‘cru-
cial’ public health interpretation, not least because
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life disparity can differ between societies with similar
life expectancies.8,9
One example is research by van Raalte et al., which
showed that in the USA, where e0 increased by
approximately 10% for men and 5% for women over
1980–2014, lifespan variation (measured as standard
deviation) fluctuated then increased.10 e0 in the USA
then declined every year since 201511 driven by what
havebeen termed ‘deaths of despair’,12,13 fromalcohol,
other drugs and suicide.13 Researchers concluded that
had lifespan variation been monitored more closely,
the mid-life mortality crisis in the USA could perhaps
have been identified earlier.10
To see if lifespan variation might have been simi-
larly useful in understanding the recent divergence of
e0 trends in the UK, we extend the analysis of life
disparity to four other high-income countries: the
UK, where, like the USA, gains in e0 have trailed
behind those in other industrialised countries14;
Japan, which has seen sustained progress; and
France and Canada, neighbours of the UK and
USA, respectively, which lie in the middle. We ask
whether e0 and life disparity in combination can (a)
identify changes that could otherwise be missed and
(b) detect changes in trends earlier.
Terminology
To ensure consistency and understanding of the terms
used throughout this paper, Box 1 provides defin-
itions from leading experts in the fields of demog-
raphy and population health.




A mortality rate that can be calculated based on age-specific
mortality rates for two or more populations, based on applying
these populations’ separate age-specific mortality rates to a
common (‘reference’ or ‘standard’) population age-structure. A
number of different standard age structures exist; the European
Standard Population is one of the most commonly used.
Eurostat, 201315
Life expectancy A population-based statistical measure of the average number of
years a person has before death. Life expectancies can be cal-
culated for any age and give the further number of years a
person can, on average, expect to live given the age they have
attained.
Life expectancy of a population at a certain point in time reflects
the average number of years and individual would live if they
faced during their entire life the current ASMRs, thus it gives
the expected average length of life based on the current mor-
tality pattern. Because age-specific mortality rates change over
time, life expectancy does not accurately predict the actual
number of years an individual will live.
Office for National Statistics
(ONS), 202016
Smits and Monden, 200917
Life expectancy
at birth (e0)
Life expectancy at birth can be denoted as e0, life expectancy at
5 years old as e5, and so on.
e0 is often simply referred to as life expectancy and is the most
common metric of survival. It is the hypothetical average age at
deaths given age-specific death rates in a given year.
Van Raalte AA et al., 201810
Lifespan variation (LV) Lifespan variation is a class of measures which calculate the
amount of heterogeneity in age at death across all individuals in
a population.
LV can be measured by using an index of variation or inequality.
Seamen et al., 20195
Van Raalte AA et al., 201810
Life disparity (LD) Life disparity is one measure of lifespan variation, representing the
average remaining life expectancy at the age when death occurs.
It is a measure of life years lost due to death.
Vaupel JW et al., 20116
Threshold age Calculated from life tables, the ‘cut-off ’ age where averting deaths
before that age reduces LD, and averting deaths after it
increases LD.
Zhang and Vaupel, 200918
390 Journal of the Royal Society of Medicine 114(8)
Methods
Data source
We extracted sex- and age-specific mortality rates
from the Human Mortality Database (HMD) from
1947 until the latest available year (2017 or later) for
the USA, Japan, UK, France and Canada, ages 0–
100. HMD smoothes mortality rates at older ages
(80þ).a We present data from 1975 to the latest avail-
able year, unless otherwise stated. Ethical approval
was not required.
Analytical approach
First, we report e0. Second, we measure lifespan var-
iation using life disparity, replicating the method
developed by Vaupel et al.6 Box 2 provides an over-
view of this methodology, for which the full code and
analyses undertaken can be found on Github.b
Finally, we present trends in age-specific mortality
to identify which age groups contributed to these
changes.
Life disparity calculations. Life disparity (denoted ey)
is defined as ‘the average remaining life expectancy
at the ages when death occurs’. It is calculated
by summing age-specific contributions for all
ages up to a maximum lifespan age (o) which in
our calculations is set to 100 years of age. These
age-specific contributions are defined as the product
of ex and fx, where ex is defined as the remaining life
expectancy at age x and fx the life table distribution
of deaths up to age x.6 See the supplementary appen-
dix in Vaupel et al. (2011) for a more complete
definition. The values shown in the bottom row
of Figure 1a and b are these age-specific contribu-
tions, exfx, with selected values of age, x, on the hori-
zontal axis. The values shown in the bottom row of
Figure 2 are life disparity (ey), which is the sum of
these age-specific contributions up to age o. All cal-
culations are based on period life tables.
Results
Figure 1a and b show the contribution of deaths at
different ages to overall life disparity using the exam-
ple of the USA and Japan, respectively, for 1947,
1975 and 2017. In each, the top panels show improve-
ments in period survival by age over time, with age on
the x axis and the proportion of people surviving to a
given age on the y axis. Over time, as people live
longer, the curve shifts to the right due to ‘compres-
sion of mortality’ or the ‘rectangularisation’ of the
survival curve: mortality decreases are steeper at
younger than older ages.19,20
The lower panels show the age-specific contribu-
tions to life disparity by deaths at different ages.
Deaths in infancy and early childhood are on the
left and those in adulthood on the right. In 1947,
both by infant mortality and deaths throughout
working and retirement ages were making an import-
ant contribution to life disparity, but the dramatic fall
in deaths in children and, in Japan, people in their
20s, means that, by 2017, life disparity is largely due
to variations in age of deaths at older ages. In 1975
and 2017, total life disparity was higher in the USA
than in Japan, mostly due to the greater contribution
from deaths at ages up to the mid-1970s in the USA.
Put another way, in 1947, a higher proportion of
deaths in Japan were in younger ages but by 1975,
this had reversed.
Life expectancy at birth (e0) and life disparity
Next, we present trends in e0 and life disparity for
each country from 1975 to at least 2017. Japan has
had the highest e0 for females since approximately
1980 and for males from 1975, improving annually,
except for a brief fall after 2011 that coincided with
the Tohoku earthquake and tsunami, when almost
16,000 people were killed on one day.21 For females,
the USA and UK consistently rank lower than the
other countries, with stalling e0 from 2010 onwards.
A similar pattern is seen for males, but with France
following a similar trajectory to the UK. Canada
shows steady improvements for both males and
females, with a slight stalling seen for males in most
recent years.
With life disparity, all countries demonstrate a
downward trend between 1975 and 2000, albeit with
a transient interruption among males in France and
the USA in the 1980s and among females in Japan in
the 1990s. Since 2010, life disparity has increased
markedly in Canada and the USA, and slightly in
the UK, also. In Japan, life disparity increased in
2011 for males especially, which may reflect the
impact of the earthquake, before falling again.
Figure 3 zooms in on life disparity since 2000,
since the majority of changes in e0 occur after 2010.
Increases in life disparity in USA and Canada are
clearer. The situation in the UK is less clear but for
males there appears to be a divergence from the
Japanese sustained downward trend, while for
females they continue broadly in parallel, although
care is necessary as there are fluctuations over time
and changes in the UK after 2015 may reflect year-
on-year variability.
Hiam et al. 391
Probability of dying in the next 12 months
Deaths in which age groups are driving changes in life
disparity? To answer this, we next examine 12-month
death risks at birth, 40, 80 and 90 years of age (see
White22 and Christensen et al.23). In Figure 4, the y
axis is on a log scale; a straight line means constant
percentage rate reduction per year over time.
For some countries/ages, such as older Japanese
females, the series looks like a straight line, but for
others it does not. Figure 4 shows a reversal of
improving trends in mortality at age 40 years for all
countries since 2010, more marked in some
populations.
At under one year (age 0), previously declining
trends slowed in the USA, UK, France and
Canada, in females, and in males in the UK and
France. However, at age 40 years, the USA, again
with a markedly higher risk for both males and
females, shows a clear increase since 2010, more so
in males. In Canada and the UK, risk at age 40 years
increased more recently. In France, trends continued
downwards. At ages 80 and 90 years, the USA no
longer has the highest risk; the UK does.
Figure 1. (a) Changing mortality survivorship curve and contributions of deaths at different ages to life disparity contribution in
the USA, 1947, 1975 and 2017. (b) Changing mortality survivorship curve and contributions of deaths at different ages to life
disparity contribution in Japan, 1947, 1975 and 2017.
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Discussion
We asked whether lifespan variation, measured as life
disparity, could (a) identify changes that otherwise
would be missed and (b) detect changes in trends ear-
lier, in the context of the recent divergence from ear-
lier trends in e0 in five high-income countries, and
thus whether life disparity should be considered
alongside e0 in routine monitoring of population
health. We found a deviation from earlier trends in
the USA, UK and Canada in both e0 and life dispar-
ity, to varying degrees, but it is not clear that these
were preceded by increasing life disparity in all cases.
By contrast, existing trends largely held for Japan,
and, to a lesser extent, France.
When mortality by age was examined, it seems
the increase in life disparity in the USA and
Canada may be driven by an increase in young- and
mid-age mortality. This is consistent with theory and
other evidence on how reductions in premature mor-
tality contribute to the decreases in life disparity seen
in many countries.6,18
What are the practical implications of our findings?
In the USA, we show that rising life disparity coin-
cided with falling e0, with increases seen in young-
and mid-age mortality, consistent with previous find-
ings.10 These findings occur in the context of the
unprecedented reversal in e0 in the USA since
Figure 1. Continued.
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2015.24 In the USA and, more recently, the UK, a rise
in mid-age mortality from ‘deaths of despair’12,13,25
plus stagnating rates in improvements from cardio-
vascular disease moratlity26,27 appear to be important
contributors to stagnating and declining e0. US
research suggests that these largely reflect ‘worsening
health among working-age individuals of lower socio-
economic status’ consistent with evidence that
increasing numbers of people are experiencing ever
more precarious lives.28
Our findings are also consistent with evidence
from Statistics Canada,29 which found that while
death rates were falling at older ages, at ages 20–44
years, especially among men, they were increasing.
This was attributed largely to the opioid crisis
which was afflicting several provinces.30 Indeed, e0
for men fell in British Columbia and remained
unchanged in Ontario, while it continued to increase
in others.
An historical example of ‘mortality crises’ comes
from the breakdown of the USSR in the 1990s in
Central and Eastern Europe. Aburto and van
Raalte found that changes in life disparity were
greater than those in e0, with the changes in life
disparity driven by increasing midlife mortality.31
Furthermore, e0 and life disparity varied
independently of each other. It may be that some-
thing similar is occurring in mid-life in the USA
and Canada.
In contrast, except for when the earthquake struck
in 2011, Japan continued to make good progress in
both e0 and life disparity in the 2010s even during
Figure 2. Life expectancy at birth (top) and life disparity over time (bottom), 1975–2017.
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periods of long-term low economic growth, and
health inequalities did not worsen.32
Can life disparity be used to detect changes in
population health trends earlier?
We show increasing life disparity coincided with
changes in e0, but cannot conclude that monitoring
life disparity would have detected or predicted stal-
ling and falling of e0 earlier in the countries exam-
ined. Indeed, existing research demonstrates that an
increase in life disparity in isolation may cause a
public health ‘false alarm’. A study of two popula-
tions with increasing longevity, Japan and Hong
Kong, showed that life disparity can increase where
no adverse trends in mortality are occurring at any
age, and while e0 continues to increase.8 Conversely,
analysis of the burden of COVID-19 on mortality in
the UK found lifespan inequality decreased during
the first year of the pandemic, while e0 also
decreased.3 In both examples, the utility of life dis-
parity is as complementary to e0 – a rising life dis-
parity in the context of stagnating or falling e0 may
indicate emerging public health challenges in a given
population but a decreasing life disparity in isolation
does not indicate a healthy population. In this
respect, our findings support the emerging concerns
about the situation in Canada.
The concept of the ‘threshold age’ is another meas-
ure which may complement the utility of life disparity
in monitoring population health. The negative correl-
ation between increasing e0 and reducing life dispar-
ity is typically due to progress in reducing premature
mortality – reducing deaths at older ages can increase
life disparity,6 as demonstrated in the Hong Kong
example.8 Zhang and Vaupel classified the different
effects of ‘early’ deaths from ‘late’ deaths on life dis-
parity, separated by the calculation of a ‘threshold
age’ – averting deaths before that age reduces life
disparity, while averting deaths after increases life
disparity.18 Vaupel et al. show the ‘threshold age’
classifies deaths at late ages as premature or early:
for example, in Japanese females, deaths up to the
age of 85 years were considered premature.6 While
considering a death aged 85 years as premature may
be counterintuitive for public health and policy
makers, monitoring of the ‘threshold age’ through
life tables may provide additional insights. In Hong
Kong, life disparity increased alongside increased
threshold age with no apparent slowdown in e0
gains.8 By contrast, we show that in the USA, life
disparity increased alongside slowdown and decreases
Figure 3. Life disparity for females and males, 2010–2017.
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in e0. Thus, it may be that the threshold age in the
USA also fell, in contrast to the increase in Hong
Kong, and a rising life disparity in the context of
stalling or falling threshold age may also indicate
population health challenges.
We propose that future research could focus on
the relationship over time between changes in life
disparity, perhaps alongside stalling or falling thresh-
old age, and in e0. If life disparity increases alongside
falling threshold age, followed by stalling or declining
e0, with a lag impact on e0, this may provide a warn-
ing of declining population health, itself often a
marker of societal problems. This also gives caution
to viewing e0 as a measure of population health in
isolation – while this is not a substitute for detailed
demographic analysis, we suggest that life disparity
does offer a simple measure that can provide useful
information when undertaking international com-
parisons of trends over time.
Strengths and limitations of the study
The Human Mortality Database has rigorous data
quality requirements and standardisation procedures
and is widely accepted as reliable for international
comparison.33 The methods used to calculate life dis-
parity and probability of dying at 12 months replicate
those of experts in the field, and were checked against
code supplied by one of the pioneers in using these
methods.6,22,23 We compared the countries with the
best and worst rates of average annual increase in
period life expectancy at birth, as identified by the
Figure 4. Probability of dying in the next 12 months by age in years, 1975–2017.
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Office for National Statistics,14 thus removing bias
from country selection; comparison with geographic-
ally and politically similar nations demonstrated
reversal of trends is not inevitable.
There are some limitations. For example, the UK
is treated as a single entity, concealing differences
between the devolved nations. Research comparing
inequality in age of death in Scotland to England
and Wales found Scotland had higher lifespan vari-
ation due to lower old age mortality and higher pre-
mature mortality.34
Furthermore, the data are aggregated, so it is not
possible to examine differences by factors such as
race, gender or the social determinants of health
such as employment status. This is undoubtedly rele-
vant: evidence from Denmark and Finland showed
inequalities in improvements in lifespan variation,
with stagnation in lower income quartiles and
manual occupational classes compared to mortality
compression, i.e. lifespan variation decreases among
those in ‘more favourable social positions’.20,35 In
addition, evidence from Europe shows those with
lower educational attainment not only experience
shorter life expectancies, but also greater uncertainty
about the age they will die due to higher lifespan
variation.36
Finally, examining five countries precluded con-
sidering each individual trajectory in depth, or
exploring all fluctuations.
As such, future research might consider two broad
areas. First, the development and testing of comple-
mentary measures to e0 for monitoring population
health, as outlined above. Second, the public health
and policy implications of the findings presented here
at both international and national level in order to
inform appropriate public health interventions and
health policy.
Conclusion
The data presented here show trends in population
health, measured as e0 and life disparity, in five high-
income countries. They support the existing evidence
that the worsening of e0 and life disparity in the USA
and, of e0 in the UK, were not inevitable, and neither
are continuing adverse trends. France and Japan both
experienced periods of downturn but recovered and
have been able to continue with improving trajec-
tories in both e0 and life disparity. They also indicate
that in those nations where e0 is stalling or falling –
Canada, the UK and USA – rising mid-age mortality
(such as at age 40) may be a key contributor. This
highlights that when measuring the progress of
nations, it is important to look not only at overall
deaths but their distribution.
Life disparity can complement life expectancy at
birth in monitoring population health, but should not
be viewed in isolation.
Data availability
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Lifespan variation by occupational class: compres-
sion or stagnation over time? Demography 2014; 51:
73–95.
36. van Raalte AA, Kunst AE, Deboosere P, Leinsalu M,
Lundberg O, Martikainen P, et al. More variation in
lifespan in lower educated groups: evidence from 10
European countries. Int J Epidemiol 2011; 40:
1703–1714.
Hiam et al. 399
